<DOC>
	<DOCNO>NCT01840059</DOCNO>
	<brief_summary>The purpose study determine whether renal sympathetic denervation ( RSD ) ( treatment lower activity sympathetic nervous system ) useful management patient heart failure preserve ejection fraction ( HF-PEF ) .</brief_summary>
	<brief_title>Renal Denervation Heart Failure With Preserved Ejection Fraction</brief_title>
	<detailed_description>Increasing evidence suggest important role activation sympathetic nervous system ( SNS ) heart failure preserve leave ventricular ejection fraction . The current study aim evaluate efficacy renal sympathetic denervation modulation SNS patient HF-PEF .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>EF &gt; 40 % NHYA 23 Evidence HFPEF ( mixture dilate leave atrium , leave ventricular hypertrophy , raise E/E ' , elevate LVEDP/PCWP , raise BNP ) Previously document EF &lt; 40 % Hypertrophic , restrictive , dilate cardiomyopathy Significant valvular heart disease Unfavourable renal artery anatomy renal denervation eGFR &lt; 45 Contraindication MRI Myocardial infarction , unstable angina cerebrovascular accident last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Cardiac Failure</keyword>
	<keyword>Autonomic Denervation</keyword>
</DOC>